Artwork

Content provided by Michigan Medicine Department of Communication and Michigan Medicine Podcast Network. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Michigan Medicine Department of Communication and Michigan Medicine Podcast Network or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

What are the Implications of the Approval of Aduhelm (Aducanumab) to the US Healthcare System?

37:46
 
Share
 

Manage episode 446201003 series 3609642
Content provided by Michigan Medicine Department of Communication and Michigan Medicine Podcast Network. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Michigan Medicine Department of Communication and Michigan Medicine Podcast Network or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.

In this episode we continue our discussion of the implications of the approval of the Alzheimer’s drug Aduhelm (generic name Aducanumab). Our guest this week is Professor Nicholas Bagley. Bagley is a professor of law at the University of Michigan Law School and a contributing writer to the Atlantic. Recently he wrote an article titled “The Drug that Could Break American Health Care” that discusses some of the broader (unintended) consequences of the approval of Aducanumab. In this episode we discuss some of the broader cost implications of the new drug.

PRODUCER’S NOTE: Since the recording of this interview, Medicare officials have announced the largest ever dollar-amount rate hike for Part B coverage citing the need to build contingency reserves to potentially cover the Alzheimer’s drug, Aduhelm. Professor Bagley discusses the concern of the cost of Aduhelm to the US Healthcare System in this Minding Memory episode.


The transcript for this episode can be found here.

Related Links:

You can subscribe to Minding Memory on Apple Podcasts, Spotify, Google Podcasts or wherever you listen to podcasts.



Hosted on Acast. See acast.com/privacy for more information.

  continue reading

40 episodes

Artwork
iconShare
 
Manage episode 446201003 series 3609642
Content provided by Michigan Medicine Department of Communication and Michigan Medicine Podcast Network. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Michigan Medicine Department of Communication and Michigan Medicine Podcast Network or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.

In this episode we continue our discussion of the implications of the approval of the Alzheimer’s drug Aduhelm (generic name Aducanumab). Our guest this week is Professor Nicholas Bagley. Bagley is a professor of law at the University of Michigan Law School and a contributing writer to the Atlantic. Recently he wrote an article titled “The Drug that Could Break American Health Care” that discusses some of the broader (unintended) consequences of the approval of Aducanumab. In this episode we discuss some of the broader cost implications of the new drug.

PRODUCER’S NOTE: Since the recording of this interview, Medicare officials have announced the largest ever dollar-amount rate hike for Part B coverage citing the need to build contingency reserves to potentially cover the Alzheimer’s drug, Aduhelm. Professor Bagley discusses the concern of the cost of Aduhelm to the US Healthcare System in this Minding Memory episode.


The transcript for this episode can be found here.

Related Links:

You can subscribe to Minding Memory on Apple Podcasts, Spotify, Google Podcasts or wherever you listen to podcasts.



Hosted on Acast. See acast.com/privacy for more information.

  continue reading

40 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide

Copyright 2025 | Privacy Policy | Terms of Service | | Copyright
Listen to this show while you explore
Play